Search for: "Ely v. State" Results 361 - 380 of 1,089
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
7 Sep 2010, 6:10 pm by Kelly
Highlights this week included: CAFC: Disclosure that merely allows PHOSITA to ‘envision’ the claimed invention fails written description: Goeddel v Sugano (Peter Zura’s 271 Patent Blog) (Patently-O) (Patent Prospector) Evista (Raloxifene) – US: CAFC upholds decision against Teva: Eli Lilly & Co v Teva Pharmaceuticals USA, Inc (Patent Docs) (The IP Factor) Aranesp (Darbepoetin) – EU: ECJ says ‘no’ to Kirin Amgen,… [read post]
24 Mar 2010, 5:57 am by Adam Chandler
United States, released earlier this month. [read post]
29 Jan 2018, 2:57 am
 The UCL debate on the UK Supreme Court decision Actavis v Eli Lilly ("Equivalents: K = Na. [read post]
15 Apr 2017, 4:17 am
 Tune in LIVE for tomorrow's Eli Lilly v Actavis Supreme Court showdownThe Supreme Court was live online to hear Tom Mitcheson QC (supported by  Andrew Waugh QC and leading Stuart Baran) for Eli Lilly against Danny Alexander QC (leading Thomas Raphael QC) for Actavis.Oldie but goldie - when is old prior art a suitable starting point for inventive step analysis? [read post]
13 May 2014, 9:23 am
"All this is compliant with the GAT and Folien decisions and the Corte di Cassazione ruling, as well the UK decision in Joined cases Actavis Group hf v Eli Lilly & Company (USA) and Medis ehf v Eli Lilly & Company (USA) [here]. [read post]
29 Jan 2020, 12:34 am
Finally, this   part of the book discusses the impact of the ruling in Regents of the University of California v Eli Lilly & Co and how  this case has influenced the application of the written description requirement in the US. [read post]
7 Aug 2018, 10:05 pm by Mark Summerfield
  Prior to this change, advice provided by foreign practitioners was not protected by patent attorney privilege (Eli Lilly & Company v Pfizer Ireland Pharmaceuticals (No 2) [2004] FCA 850: ‘The language of s 200(2) is clear. [read post]
18 Jul 2014, 11:55 am
June. 13, 2013), holding essentially that, since those meanies on the United States Supreme Court aren’t letting plaintiffs sue generic manufacturers, we’ll change Alabama common law and let them sue someone else. [read post]
4 Apr 2024, 6:32 am by Michael C. Dorf
He successfully argued New York Times v. [read post]